These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 5014367)

  • 1. Immunologic unreactivity in bladder cancer patients.
    Olsson CA; Rao CN; Menzoian JO; Byrd WE
    J Urol; 1972 Apr; 107(4):607-9. PubMed ID: 5014367
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    Trans Am Assoc Genitourin Surg; 1973; 65():66-72. PubMed ID: 4763514
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA; Chute R; Rao CN
    J Urol; 1974 Feb; 111(2):173-6. PubMed ID: 4810758
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune response in bladder cancer patients.
    Brosman S; Elhilali M; Vescera C; Fahey J
    J Urol; 1979 Feb; 121(2):162-9. PubMed ID: 423328
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced in vivo cell-mediated immune responses to mumps, tuberculin, and streptokinase/streptodornase but not to Candida albicans in oral lichen planus.
    Simark-Mattsson C; Jontell M; Bergenholtz G; Dahlgren UI
    J Dent Res; 1999 Nov; 78(11):1704-10. PubMed ID: 10576166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological responsiveness in patients with bladder cancer.
    Fahey JL; Brosman S; Dorey F
    Cancer Res; 1977 Aug; 37(8 Pt 2):2875-8. PubMed ID: 872117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck.
    Lundy J; Wanebo H; Pinsky C; Strong E; Oettgen H
    Am J Surg; 1974 Oct; 128(4):530-3. PubMed ID: 4429642
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer concepts of cancer of the colon and rectum: delayed hypersensitivity responses of patients with carcinoma of the colon and other solid tumors.
    Kronman BS; Shapiro HM; Localio SA
    Dis Colon Rectum; 1972; 15(2):106-10. PubMed ID: 5026786
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
    Hollinshead AC
    Natl Cancer Inst Monogr; 1978 Dec; (49):255-6. PubMed ID: 748779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anergy and tryptophan metabolism in bladder cancer.
    Romas NA; Ionascu L; Ionescu G; Wechsler M; Tannenbaum M; Veenema RJ
    J Urol; 1976 Apr; 115(4):387-9. PubMed ID: 1263311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hypersensitivity to tuberculin and other antigens in a hospital population.
    Walls RS
    S Afr Med J; 1974 Oct; 48(49):2073-6. PubMed ID: 4609390
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delayed skin reaction in a group of 400 hospital patients: control study (author's transl)].
    Orriols R; Morell F; Fité E; Ruiz J; Tornos C; Sanz R; Morera J
    Med Clin (Barc); 1981 Oct; 77(6):240-2. PubMed ID: 7321638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic and prognostic significance of delayed hypersensitivity skin testing in patients with urological cancer.
    Williams G; Castro JE
    Br J Urol; 1975 Feb; 47(1):97-101. PubMed ID: 1131501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay.
    Troye M; Perlmann P; Larsson A; Blomgren H; Johansson B
    Int J Cancer; 1977 Aug; 20(2):188-98. PubMed ID: 892930
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular immunity in bladder cancer patients.
    Guinan P; McKiel C; Flanagan M; Bhatti R; Pessis D; Ablin RJ
    J Urol; 1978 Jun; 119(6):747-9. PubMed ID: 660759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response in bladder cancer.
    Merrin C; Han T
    J Urol; 1974 Feb; 111(2):170-2. PubMed ID: 4810757
    [No Abstract]   [Full Text] [Related]  

  • 17. Immediate and delayed hypersensitivity in chronic dermatophytosis.
    Sorensen GW; Jones HE
    Arch Dermatol; 1976 Jan; 112(1):40-2. PubMed ID: 129033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT; Sparks FC; Eilber FR; Morton DL
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.
    Gotoff SP; Lolekha S; Lopata M; Kopp J; Kopp RL; Malecki TJ
    J Lab Clin Med; 1973 Oct; 82(4):682-91. PubMed ID: 4585463
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.